Literature DB >> 1516412

Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis.

K E Sietsema1, M Kraft, L Ginzton, O P Sharma.   

Abstract

Exercise intolerance and exertional dyspnea are common complaints in patients with sarcoidosis. Although in many cases these complaints are attributable to restrictive or obstructive lung mechanics or inefficiency of pulmonary gas exchange, other processes also may contribute to impairment in exercise function and may not be readily detected or distinguished from problems of lung mechanics on the basis of symptoms or routine laboratory testing. To identify the frequency and etiology of impaired exercise capacity in sarcoidosis patients with mild lung disease, integrative cardiopulmonary exercise testing was performed in 23 patients. Breath-by-breath measurements were made of gas exchange, ventilation, and heart rate. In 9 of 20 evaluable patients, the oxygen uptake (VO2) at the anaerobic threshold was low, and/or the rate of increase of VO2 was abnormal relative to work rate or heart rate, suggesting a defect in cardiocirculatory function. Resting and exercise echocardiography revealed normal left ventricular ejection fractions and wall motion in all nine of these patients, but findings suggestive of right ventricular hypertrophy and/or right ventricular dysfunction were present in five. Abnormal responses of VO2 during exercise are common in patients with sarcoidosis and may be due to subclinical impairment of right-sided cardiac function.

Entities:  

Mesh:

Year:  1992        PMID: 1516412     DOI: 10.1378/chest.102.3.838

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.

Authors:  Arda Kiani; Alireza Eslaminejad; Mohsen Shafeipour; Fatemeh Razavi; Seyyed Reza Seyyedi; Babak Sharif-Kashani; Habib Emami; Mehrdad Bakhshayesh-Karam; Atefeh Abedini
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

3.  Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis.

Authors:  Agnaldo José Lopes; Sara Lucia Silveira de Menezes; Cristina Márcia Dias; Juliana Flávia de Oliveira; Míriam Raquel Meira Mainenti; Fernando Silva Guimarães
Journal:  Lung       Date:  2011-08-20       Impact factor: 2.584

4.  The six-minute walk test in patients with pulmonary sarcoidosis.

Authors:  Esam H Alhamad
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

5.  Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?

Authors:  Rik G J Marcellis; Antoine F Lenssen; Geeuwke J de Vries; Robert P Baughman; Chris P van der Grinten; Johny A Verschakelen; Jolanda De Vries; Marjolein Drent
Journal:  Lung       Date:  2012-11-09       Impact factor: 2.584

6.  Reduction of exercise capacity in sarcoidosis in relation to disease severity.

Authors:  Anastasios Kallianos; Paul Zarogoulidis; Fotini Ampatzoglou; Georgia Trakada; Elias Gialafos; Georgia Pitsiou; Athanasia Pataka; Lemonia Veletza; Konstantinos Zarogoulidis; Wolfgang Hohenforst-Schmidt; Dimitris Petridis; Ioannis Kioumis; Aggeliki Rapti
Journal:  Patient Prefer Adherence       Date:  2015-08-18       Impact factor: 2.711

7.  Nitrogen single-breath washout test for evaluating exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease.

Authors:  C A L Deus; P S Vigário; F S Guimarães; A J Lopes
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590

8.  Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.

Authors:  A J Lopes; S L S Menezes; C M Dias; J F Oliveira; M R M Mainenti; F S Guimarães
Journal:  Braz J Med Biol Res       Date:  2012-02-16       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.